Latest News and Press Releases
Want to stay updated on the latest news?
-
MARTINSRIED, Germany, June 4, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) announced today that its management will give company presentations at three...
-
MARTINSRIED, Germany, May 18, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) announced today the start of a further two oncology-focused therapeutic antibody...
-
MARTINSRIED, Germany, May 5, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) announced today that it has received a milestone payment from its collaboration with...
-
MARTINSRIED, Germany, April 28, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) today announced its financial results for the three months ended March 31, 2009...
-
MARTINSRIED, Germany, April 23, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) will publish its first three months' 2009 results on April 28, 2009 at 7:00 a.m....
-
MARTINSRIED, Germany and MUNICH, Germany, March 13, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment:TecDAX) announced today that the European Patent Office has granted a...
-
Sound Financial Foundation to Support Increased R&D Investment Press Conference Call (in German) Today At 09:30 am CET Conference Call and Webcast of the Analyst Meeting and...
-
MARTINSRIED, Germany, Feb. 20, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) will publish its Annual Financial Results 2008 on February 26, 2009 at 7:30 a.m....
-
MARTINSRIED, Germany, Feb. 20, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment, TecDAX) announced today the appointment of a new Head of Pre-clinical Development &...
-
MARTINSRIED, Germany, Jan. 29, 2009 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR) (Prime Standard Segment) announced today the appointment of a new Head of its AbD Serotec business for research and...